UBS Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,129
Closed -$1K 10271
2021
Q4
$1K Buy
+1,129
New +$1K ﹤0.01% 9065
2021
Q3
Sell
-3,834
Closed -$9K 9477
2021
Q2
$9K Buy
+3,834
New +$9K ﹤0.01% 7108
2020
Q4
Sell
-18,566
Closed -$43K 8024
2020
Q3
$43K Buy
+18,566
New +$43K ﹤0.01% 4916
2020
Q2
Sell
-245
Closed 7659
2020
Q1
$0 Buy
+245
New ﹤0.01% 7599
2019
Q4
Sell
-2,954
Closed -$9K 7523
2019
Q3
$9K Sell
2,954
-1,724
-37% -$5.25K ﹤0.01% 6286
2019
Q2
$19K Buy
4,678
+1,577
+51% +$6.41K ﹤0.01% 5800
2019
Q1
$15K Sell
3,101
-238
-7% -$1.15K ﹤0.01% 5737
2018
Q4
$8K Buy
3,339
+2,587
+344% +$6.2K ﹤0.01% 6459
2018
Q3
$5K Buy
752
+595
+379% +$3.96K ﹤0.01% 6610
2018
Q2
$1K Buy
+157
New +$1K ﹤0.01% 6961
2018
Q1
Sell
-803
Closed -$7K 7236
2017
Q4
$7K Buy
803
+93
+13% +$811 ﹤0.01% 6291
2017
Q3
$8K Buy
710
+437
+160% +$4.92K ﹤0.01% 6116
2017
Q2
$11K Sell
273
-407
-60% -$16.4K ﹤0.01% 5799
2017
Q1
$33K Buy
680
+32
+5% +$1.55K ﹤0.01% 4897
2016
Q4
$21K Sell
648
-60
-8% -$1.94K ﹤0.01% 5553
2016
Q3
$29K Buy
708
+483
+215% +$19.8K ﹤0.01% 5106
2016
Q2
$7K Sell
225
-46
-17% -$1.43K ﹤0.01% 6103
2016
Q1
$17K Buy
271
+46
+20% +$2.89K ﹤0.01% 5497
2015
Q4
$9K Sell
225
-194
-46% -$7.76K ﹤0.01% 6080
2015
Q3
$23K Buy
419
+31
+8% +$1.7K ﹤0.01% 5357
2015
Q2
$43K Buy
+388
New +$43K ﹤0.01% 4878
2015
Q1
Sell
-146
Closed -$8K 6913
2014
Q4
$8K Buy
+146
New +$8K ﹤0.01% 6149